Danielle Carnival, Ph.D. | she/her

Chief Executive Officer
Danielle Carnival, Ph.D. is a national leader in health, research, and policy. She led the White House Cancer Moonshot from 2021- 2025 which delivered more than 125 federal actions and steps from more than 250 private sector organizations to improve the experience and outcomes for people facing cancer. At the same time, she led a White House team to drive policy and programmatic progress in the areas of research and regulatory infrastructure, public health, and biosecurity, among others. As the inaugural CEO of I AM ALS, Dr. Carnival provided strategic leadership and management for the patient-driven organization that aims to provide key resources to the community and create opportunities for patients to lead progress and cures. As Vice President of the Biden Cancer Initiative, she led organizational, program, policy, and partnership development.Dr. Carnival also worked at the White House from 2010-2017, where she leveraged her scientific expertise to make progress in the areas of health and biomedical research policy, STEM education, and advancing equity and promoting diversity in STEM fields. She was integral in developing the framing and goals for the Cancer Moonshot, managed the team executing on those goals, led multiple White House Science Fairs and the White House Cancer Moonshot Summit, and contributed to signature reports and recommendation implementation from the President’s Council of Advisors on Science and Technology and the President's Job Council. Danielle Carnival earned her Ph.D. in Neuroscience from Georgetown University and a B.S. in Biochemistry from Boston College.